Therefore, the intrahepatic level of aromatase may be reasonably postulated to be influenced by that of the factors above, which is different among several types of inflammatory or neoplastic disease such as hepatitis, cirrhosis, steatosis, HCC, and MLC [35]. Here, CYP19A1 is linked to steatosis.